Two-dimensional (2D) magnetic materials have attracted much attention due to their unique magnetic properties and promising applications in spintronics. Here, we report on the growth of ferrous chloride (FeCl2) films on Au(111) and graphite with atomic thickness by molecular-beam epitaxy (MBE) and the layer-dependent magnetic properties by density functional theory (DFT) calculations. The growth follows a layer-by-layer mode with adjustable thickness from sub-monolayer to a few layers. Four types of moiré superstructures of a single-layer FeCl2 on graphite and two types of atomic vacancies on Au(111) have been identified based on high-resolution scanning tunneling microscopy (STM). It turned out that the single- and few-layer FeCl2 films grown on Au(111) exhibit a 1T structure. The DFT calculations reveal that a single-layer 1T-FeCl2 has a ferromagnetic ground state. The minimum-energy configuration of a bilayer FeCl2 is satisfied for the 1T–1T structure with ferromagnetic layers coupled antiferromagnetically. These results make FeCl2 a promising candidate as ideal electrodes for spintronic devices providing large magnetoresistance.

No abstract

Controlling the self-assembly of molecules on solid surfaces is of great importance for creating new functional nanostructures. In this work, phase transitions in the self-assembled structure of the 1,3,5-tris­(3-carboxyphenyl)­benzene (mTCPB) molecule on the Ag(111) surface at different annealing temperatures are characterized by ultrahigh vacuum scanning tunneling microscopy, which reflects the different deprotonation levels of the mTCPB molecule. We also demonstrate that the two-dimensional chirality of the precursor is a powerful tool for steering the supramolecular structures on surfaces.

The van der Waals materials down to the monolayer (ML) limit provide a fertile platform for exploring the low-dimensional magnetism and developing the novel applications of spintronics. Among them, due...

Recent studies have shown that diaporine, a novel fungal metabolic product, has a strong in vitro and in vivo anticancer effect on human non-small-cell lung and breast cancers. In this study, three human hepatocarcinoma cell lines (HepG2, Hep3B, and Huh7) were used to evaluate the efficacy of diaporine alone and in combination with the standard cytotoxic drugs oxaliplatin and doxorubicin for the treatment of liver cancer. We demonstrated that diaporine, oxaliplatin, and doxorubicin triggered a concentration- and time-dependent decrease in the number of HepG2 cells. Diaporine at a concentration of 2.5 μM showed almost 100% inhibition of cell counts at 72 h. Similar effects were observed only with much higher concentrations (100 μM) of oxaliplatin or doxorubicin. Decreases in cell numbers after 48 h treatment with diaporine, oxaliplatin, and doxorubicin were also demonstrated in two additional hepatoma cell lines, Hep3B and Huh7. The combination of these drugs at low concentration for 48 h in vitro noticeably showed that diaporine improved the inhibitory effect on the number of cancer cells induced by oxaliplatin or doxorubicin. Additionally, this combination effectively inhibited colony growth in vitro. We found that inhibition of phosphorylation of ERK1/2 significantly increased when diaporine was used in combination with other agents. In addition, we also found that when diaporine was used in combination with doxorubicin or oxaliplatin, their proapoptotic effect greatly increased. We further revealed that the induction of apoptosis in hepatoma cells after treatment is due, at least in part, to the inhibition of phosphorylation of AKT, leading to the activation of caspase-3, inactivation of poly (ADP-ribose) polymerase (PARP), and subsequently to DNA damage, as indicated by the increased level of H2AX. Based on these findings, we suggest that diaporine in combination with the standard cytotoxic drugs oxaliplatin and doxorubicin may play a role in the treatment of liver cancer.